FT819 in Subjects With B-cell Malignancies
Fate Therapeutics
Fate Therapeutics
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Allogene Therapeutics
Celgene
TILT Biotherapeutics Ltd.
Ossium Health, Inc.
Ossium Health, Inc.
Intima Bioscience, Inc.